Amgen (AMGN) Tops Q2 EPS by 51c; raises guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/5/2026
- S&P 500 up, Nasdaq at record high as megacap tech stocks rise
- Oil slips on rise in Middle East crude exports and G7 stocks release
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
- Five things to watch in markets in the week ahead
Tweet
Share
E-mail_58cbc46cd3c33.jpg)
Get Alerts AMGN Hot Sheet
Price: $403.19 +0.04%
Revenue Growth %: +5.1%
Financial Fact:
Provision for income taxes: 401M
Today's EPS Names:
VFS, PKE, More
Revenue Growth %: +5.1%
Financial Fact:
Provision for income taxes: 401M
Today's EPS Names:
VFS, PKE, More
Join SI Premium – FREE
Amgen (NASDAQ: AMGN) reported Q2 EPS of $5.00, $0.51 better than the analyst estimate of $4.49. Revenue for the quarter came in at $7 billion versus the consensus estimate of $6.67 billion.
GUIDANCE:
Amgen sees FY2023 EPS of $17.80-$18.80, versus the consensus of $17.75. Amgen sees FY2023 revenue of $26.6-27.4 billion, versus the consensus of $26.56 billion.
For earnings history and earnings-related data on Amgen (AMGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Amgen (AMGN) Reiterated at Neutral by Cantor Fitzgerald
- RBC Capital maintains Outperform rating on Insmed amid CFO change
- US stocks rise ahead of earnings season starting Thursday
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
